ELGAN Pharma
EIC Accelerator Winner From 2022
A first-in-class therapy for intestinal malabsorption in premature newborns
Israel
Articles
ELGAN Pharma Secures EIC Accelerator Funding for Innovative Neonatal Therapies
IsraelEIC Accelerator2022
Read Article